DoxorubicinAntibiotics, AntineoplasticInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsTaxoidsAntineoplastic AgentsCisplatinSoft Tissue NeoplasmsCombined Modality TherapyCell Line, TumorDrug Resistance, NeoplasmChemotherapy, AdjuvantTreatment OutcomeRemission InductionApoptosisPaclitaxelBreast NeoplasmsCaspase 12Disease-Free SurvivalCyclophosphamideTumor Suppressor Protein p53Survival AnalysisDrug Administration ScheduleNeoadjuvant TherapyNeoplasm StagingSurvival RateLung NeoplasmsEtoposideSarcomaSoft Tissue InjuriesHead and Neck NeoplasmsFluorouracilAntineoplastic Agents, PhytogenicVincristineCarcinoma, Squamous CellCardiomyopathiesSoft Tissue InfectionsIfosfamideDaunorubicinCytarabinePrognosisCarboplatinMitochondria, HeartVinblastineDNA DamageCarcinoma, Non-Small-Cell LungLeukemia, Myeloid, AcuteNeoplasm MetastasisDeoxycytidineNeoplasm Recurrence, LocalTumor Markers, BiologicalGene Expression Regulation, NeoplasticRNA, MessengerDose-Response Relationship, DrugMyocardiumRNA, Small InterferingSignal TransductionHeartRadiotherapy, AdjuvantNeutropeniaTime FactorsBone NeoplasmsMethotrexateAdenocarcinomaFollow-Up StudiesBleomycinEnzyme InductionTumor BurdenKaplan-Meier EstimateRadiotherapyChemoradiotherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiotherapy DosageMitoxantroneInfusions, IntravenousNeoplasmsGranulocyte Colony-Stimulating FactorSalvage TherapyIdarubicinAnthracyclinesHypopharyngeal NeoplasmsProspective StudiesLaryngectomyTumor Necrosis Factor-alphaDisease ProgressionLeukopeniaTransplantation, AutologousAntimetabolites, AntineoplasticP-GlycoproteinLeukemia, MyeloidNasopharyngeal NeoplasmsBrain NeoplasmsPrednisoneEpirubicinRetrospective StudiesMelphalanTesticular NeoplasmsLymphatic MetastasisOvarian NeoplasmsAntibodies, Monoclonal